USING HEPTAPEPTIDE FOR TREATING PARKINSON'S DISEASE AND METHOD OF TREATING SUCH DISEASE

摘要

FIELD: medicine, pharmaceutics.;SUBSTANCE: invention refers to chemical-pharmaceutical industry and medicine, and concerns using heptapeptide Thr-Lys-Pro-Arg-Pro-Gly-Pro (Selinc).;EFFECT: intranasal application of the preparation in the concentration of 0,15 % in dose four to six drops in each nostril every 4-5 hours for 2-3 weeks allows higher clinical effectiveness in Parkinson's disease ensured by correction of neuropsycological disorders.;3 cl, 4 ex